48 results on '"Kwon, Hyeong Ju"'
Search Results
2. ASO Visual Abstract: Restratification of Patients with Intermediate-Risk Papillary Thyroid Carcinoma
- Author
-
Moon, Gilseong, Jang, Sung Woo, Nam, Kyung-Tae, Park, Jae Hyun, Kwon, Hyeong Ju, and Yoon, Jong Ho
- Published
- 2022
- Full Text
- View/download PDF
3. P16 expression and its association with PD-L1 expression and FOXP3-positive tumor infiltrating lymphocytes in head and neck squamous cell carcinoma
- Author
-
Kim, Taeyeong, Jung, Soon-Hee, Kim, Soo-Ki, and Kwon, Hyeong Ju
- Published
- 2019
- Full Text
- View/download PDF
4. Histogram and gray level co-occurrence matrix on gray-scale ultrasound images for diagnosing lymphocytic thyroiditis
- Author
-
Shin, Young Gyung, Yoo, Jaeheung, Kwon, Hyeong Ju, Hong, Jung Hwa, Lee, Hye Sun, Yoon, Jung Hyun, Kim, Eun-Kyung, Moon, Hee Jung, Han, Kyunghwa, and Kwak, Jin Young
- Published
- 2016
- Full Text
- View/download PDF
5. Intermediate serrated polyp as an intermediate lesion of hyperplastic polyp and sessile serrated polyp/adenoma in terms of morphological and molecular features
- Author
-
Kwon, Hyeong Ju, Cho, Nam-Yun, Chang, Mee Soo, Kim, Yong Sung, and Kang, Gyeong Hoon
- Published
- 2014
- Full Text
- View/download PDF
6. Concurrent Antibody-Mediated Rejection in Post-Transplant IgA Nephropathy – Diagnosis Using a Stepwise Approach of Graft Morphology
- Author
-
Jeong, Hyeon Joo, Lee, Ji Yeun, Lim, Beom Jin, Kwon, Hyeong Ju, Kim, Yu Seun, Kim, Soon Il, Kim, Beom Seok, Huh, Kyu Ha, and Kim, Myoung Soo
- Published
- 2018
- Full Text
- View/download PDF
7. Combined use of conventional smear and liquid-based preparation versus conventional smear for thyroid fine-needle aspiration
- Author
-
Kim, Soo-Yeon, Kim, Eun-Kyung, Moon, Hee Jung, Yoon, Jung Hyun, Kwon, Hyeong Ju, Song, Mi Kyung, and Kwak, Jin Young
- Published
- 2016
- Full Text
- View/download PDF
8. Predicting lymph node metastasis in patients with papillary thyroid carcinoma by vascular index on power Doppler ultrasound
- Author
-
Lee, Ji Hye, Shin, Hyun Joo, Yoon, Jung Hyun, Kim, Eun‐Kyung, Moon, Hee Jung, Lee, Hye Sun, Kwon, Hyeong Ju, and Kwak, Jin Young
- Published
- 2017
- Full Text
- View/download PDF
9. Recurrence Risk Evaluation in Patients with Papillary Thyroid Carcinoma: Multicenter Machine Learning Evaluation of Lymph Node Variables.
- Author
-
Jang, Sung-Woo, Park, Jae-Hyun, Kim, Hae-Rim, Kwon, Hyeong-Ju, Lee, Yu-Mi, Hong, Suck-Joon, and Yoon, Jong-Ho
- Subjects
RISK of metastasis ,EVALUATION of medical care ,RESEARCH ,PATIENT aftercare ,SCIENTIFIC observation ,THYROID gland tumors ,PAPILLARY carcinoma ,MACHINE learning ,LYMPH nodes ,POSTOPERATIVE care ,DISEASE relapse ,DESCRIPTIVE statistics ,PROGRESSION-free survival ,LONGITUDINAL method - Abstract
Simple Summary: The analytic appropriateness and general applicability of lymph node-related risk factors used to predict long-term outcomes in patients with papillary thyroid carcinoma need to be validated. This study aimed to assess detailed lymph node-related risk factors and suggest new risk categories. In the present study, using the K-means clustering algorithm, we determined new cutoffs for lymph node variables besides extranodal extension: 0.2 cm and 1.1 cm for the maximal diameter of metastatic lymph node foci, 4 and 13 for the number of metastatic lymph nodes, and 0.28 and 0.58 for the metastatic lymph node ratio; new lymph node risk categories were suggested. The recurrence-free survival curves of each subgroup classified by these newly determined cutoffs showed significant differences. These newly developed risk categories might be considered when redefining risk stratification or staging systems. Background: Lymph node (LN)-related risk factors have been updated to predict long-term outcomes in patients with papillary thyroid carcinoma (PTC). However, those factors' analytic appropriateness and general applicability must be validated. This study aimed to assess LN-related risk factors, and suggest new LN-related risk categories. Methods: This multicenter observational cohort study included 1232 patients with PTC with N1 disease treated with a total thyroidectomy and neck dissection followed by radioactive iodine remnant ablation. Results: The median follow-up duration was 117 months. In the follow-up period, structural recurrence occurred in 225 patients (18.3%). Among LN-related variables, the presence of extranodal extension (p < 0.001), the maximal diameter of metastatic LN foci (p = 0.029), the number of retrieved LNs (p = 0.003), the number of metastatic LNs (p = 0.003), and the metastatic LN ratio (p < 0.001) were independent risk factors for structural recurrence. Since these factors showed a nonlinear association with the hazard ratio of recurrence-free survival (RFS) rates, we calculated their optimal cutoff values using the K-means clustering algorithm, selecting 0.2 cm and 1.1 cm for the maximal diameter of metastatic LN foci, 4 and 13 for the number of metastatic LN, and 0.28 and 0.58 for the metastatic LN ratio. The RFS curves of each subgroup classified by these newly determined cutoff values showed significant differences (p < 0.001). Each LN risk group also showed significantly different RFS rates from the others (p < 0.001). Conclusions: In PTC patients with an N1 classification, our novel LN-related risk estimates may help predict long-term outcomes and design postoperative management and follow-up strategies. After further validation studies based on independent datasets, these risk categories might be considered when redefining risk stratification or staging systems. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes
- Author
-
Park, So Yeon, Kwon, Hyeong Ju, Choi, Yoomi, Lee, Hee Eun, Kim, Sung-Won, Kim, Jee Hyun, Kim, In Ah, Jung, Namhee, Cho, Nam-Yun, and Kang, Gyeong Hoon
- Published
- 2012
- Full Text
- View/download PDF
11. Thyroid Cancers with Benign-Looking Sonographic Features Have Different Lymph Node Metastatic Risk and Histologic Subtypes According to Nodule Size
- Author
-
Shin, Dong Yeob, Lee, Young Ki, Kim, Kwang Joon, Park, Kyeong Hye, Hwang, Sena, Park, Se Hee, Kim, Eun-Kyung, Kwon, Hyeong Ju, and Lee, Eun Jig
- Published
- 2014
- Full Text
- View/download PDF
12. Watch out for the WATCHMAN
- Author
-
Youn, Jong-Chan, Pak, Hui-Nam, Kwon, Hyeong Ju, and Kang, Seok-Min
- Published
- 2015
- Full Text
- View/download PDF
13. Promoter CpG island hypermethylation during breast cancer progression
- Author
-
Park, So Yeon, Kwon, Hyeong Ju, Lee, Hee Eun, Ryu, Han Suk, Kim, Sung-Won, Kim, Jee Hyun, Kim, In Ah, Jung, Namhee, Cho, Nam-Yun, and Kang, Gyeong Hoon
- Published
- 2011
- Full Text
- View/download PDF
14. DNA methylation changes in ex-adenoma carcinoma of the large intestine
- Author
-
Kwon, Hyeong-Ju, Kim, Jung Ho, Bae, Jeong Mo, Cho, Nam-Yun, Kim, Tae-You, and Kang, Gyeong Hoon
- Published
- 2010
- Full Text
- View/download PDF
15. CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features
- Author
-
Park, Seog-Yun, Kook, Myeong Cherl, Kim, Young Woo, Cho, Nam-Yun, Jung, Namhee, Kwon, Hyeong-Ju, Kim, Tae-You, and Kang, Gyeong Hoon
- Published
- 2010
- Full Text
- View/download PDF
16. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers
- Author
-
Kim, Jung Ho, Shin, So Hyun, Kwon, Hyeong Ju, Cho, Nam Yun, and Kang, Gyeong Hoon
- Published
- 2009
- Full Text
- View/download PDF
17. CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma
- Author
-
Kim, Baek-hui, Cho, Nam-Yun, Shin, So Hyun, Kwon, Hyeong-Ju, Jang, Ja June, and Kang, Gyeong Hoon
- Published
- 2009
- Full Text
- View/download PDF
18. Optimal cutoff values of primary tumour size to better predict long‐term outcomes in patients with papillary thyroid carcinoma undergoing total thyroidectomy: A preliminary study using restricted cubic spline analysis.
- Author
-
Jang, Sung Woo, Park, Jae Hyun, Kwon, Hyeong Ju, and Yoon, Jong Ho
- Subjects
REFERENCE values ,THYROIDECTOMY ,PAPILLARY carcinoma ,THYROID cancer ,TREATMENT effectiveness ,SPLINES - Abstract
Objective: Primary tumour size (PTS) is known to be a significant prognostic factor in patients with papillary thyroid carcinoma (PTC) undergoing thyroidectomy. Although cutoff values of 2 and 4 cm are widely used in surgical extent decision and long‐term outcomes predictions, the effectiveness of arbitrary cutoff values in stratifying patients for target outcomes is questionable. This study aimed to determine new optimal cutoffs of PTS. Design, Patient And Measurements: Patients (n = 529) with PTC who underwent total thyroidectomy were retrospectively reviewed. After risk factor analysis for structural recurrence, the optimal cutoffs of PTS were automatically calculated using restricted cubic spline analysis and X‐tile software. Subgroups were classified based on the newly determined cutoff values. Both the recurrence‐free survival (RFS) and the proportion of patients in each response‐to‐therapy category, using the dynamic risk stratification system (DRS), were compared between the subgroups. Results: PTS was confirmed as an independent risk factor for structural recurrence. The optimal cutoff values were calculated as 1.4 and 3.0 cm. The subgroups stratified using these newly determined cutoffs showed significantly different RFS and DRS based on the response to initial therapy, but the subgroups classified using the cutoffs of 2 and 4 cm did not. Conclusions: The newly determined cutoff values of PTS may be useful in better stratifying patients with PTC undergoing thyroidectomy for target outcomes and can be considered as a new definition in staging and risk stratification systems. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications
- Author
-
Bae, Jeong Mo, Shin, So-Hyun, Kwon, Hyeong-Ju, Park, Seog-Yun, Kook, Myeong Cherl, Kim, Young-Woo, Cho, Nam-Yun, Kim, Nayoung, Kim, Tae-You, Kim, Donguk, and Kang, Gyeong Hoon
- Published
- 2012
- Full Text
- View/download PDF
20. Primary Bone Marrow B-Cell Lymphoma Undetected by Multiple Imaging Modalities That Initially Presented with Hypercalcemia
- Author
-
Yoo, Jin Sae, Kim, Juwon, Kwon, Hyeong Ju, and Lim, Jung Soo
- Subjects
Article Subject - Abstract
Purpose. We report a rare case of severe hypercalcemia that was ultimately diagnosed as primary bone marrow diffuse large B-cell lymphoma (BCL). Case Report. A 74-year-old male patient visited our hospital complaining of tenderness and swelling of the left knee caused by supracondylar fracture of the left distal femur. His initial blood tests showed a serum calcium level of 13.9 mg/dL, inorganic phosphorus of 4.34 mg/dL, and a serum creatinine level of 1.54 mg/dL. A serum assay of intact parathyroid hormone showed 5.24 pg/mL, and the patient’s serum 25(OH)D level was 22.33 ng/mL. To exclude malignancy, we performed imaging studies, including abdomen or chest computed tomography and positron emission tomography-computed tomography; however, no suspicious lesion was found, although the serum PTH-related peptide level was elevated at 4.0 pmol/L. A bone marrow biopsy was performed to identify any hidden hematologic malignancy. As a result, the pathology of bone marrow confirmed the presence of atypical lymphocytes that stained positive for the CD20 marker, which is consistent with BCL involving the bone marrow. Conclusion. This case highlights the importance of pursuing a thorough workup for rare underlying causes of hypercalcemia when parathyroid-related etiologies can be excluded.
- Published
- 2018
- Full Text
- View/download PDF
21. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi‐institutional study in 6 Asian countries.
- Author
-
Agarwal, Shipra, Bychkov, Andrey, Jung, Chan Kwon, Hirokawa, Mitsuyoshi, Lai, Chiung‐Ru, Hong, SoonWon, Kwon, Hyeong Ju, Rangdaeng, Samreung, Liu, Zhiyan, Su, Peng, Kakudo, Kennichi, and Jain, Deepali
- Abstract
Background: Hürthle cell‐rich nodules (HCNs) encompass non‐neoplastic to malignant lesions. There is paucity of literature on the frequency distribution of HCNs among Bethesda categories, histologic follow‐up, risk of malignancy (ROM), and risk of neoplasia (RON). The objective of this retrospective, multi‐institutional study was to determine the prevalence of the cytologic diagnostic category and surgical outcomes of patients with HCN. Methods: Nine tertiary health centers representing 6 Asian countries participated. Cases were retrieved from respective databases. The Bethesda System for Reporting Thyroid Cytopathology was used. Cytology results were correlated with surgical diagnoses. Results: Of 42,190 thyroid aspirates retrieved, 760 (1.8%) had a Hürthle cell predominance. Most (61%) were categorized as atypia of undetermined significance/follicular lesion of undetermined significance, Hürthle cell type" (AUS‐H); 35% were categorized as follicular neoplasm, Hürthle cell type (FN‐H); and 4% were categorized as suspicious for malignancy (SFM). Histologic follow‐up was available for 288 aspirates (38%). Most were benign on resection (66%), and the most common histologic diagnosis was Hürthle cell adenoma (28.5%). The ROM for AUS‐H, FN‐H, and SFM, as calculated on resected nodules, was 32%, 31%, and 71%, respectively; and the RON was 47%, 81%, and 77%, respectively. The 5 institutions that had an AUS‐H:HCN ratio below 0.5 diagnosed HCN less frequently as AUS‐H than as FN‐H. Conclusions: This is the largest, contemporary, multi‐institutional series of HCNs with surgical follow‐up. Although there was wide interinstitutional variation in prevalence and surgical outcomes, there was no significant difference in the ROM among institutions. The categories AUS‐H and FN‐H had a similar ROM for resected nodules. In a large, multi‐institutional study of Hürthle cell–rich lesions with surgical follow‐up, the incidence of Hürthle cell nodules, their Bethesda categorization on aspiration cytology, and the risks of malignancy and neoplasm are highlighted. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition.
- Author
-
Byeon, Hyung Kwon, Na, Hwi Jung, Yang, Yeon Ju, Kwon, Hyeong Ju, Chang, Jae Won, Ban, Myung Jin, Kim, Won Shik, Shin, Dong Yeob, Lee, Eun Jig, Koh, Yoon Woo, Yoon, Joo‐Heon, and Choi, Eun Chang
- Published
- 2016
- Full Text
- View/download PDF
23. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance ( AUS/ FLUS): a study applying Thyroid Imaging Reporting and Data System ( TIRADS).
- Author
-
Yoon, Jung Hyun, Kwon, Hyeong Ju, Kim, Eun‐Kyung, Moon, Hee Jung, and Kwak, Jin Young
- Subjects
- *
NEEDLE biopsy , *THYROID cancer treatment , *THYROID gland , *FOLLICULAR dendritic cells , *CYTOLOGY , *MAGNETIC resonance imaging - Abstract
Objective To evaluate the clinical significance and compare the imaging features according to the Thyroid Image Reporting and Data System ( TIRADS) between atypia of undetermined significance/follicular lesion of undetermined significance ( AUS/ FLUS) subcategories. Design & patients A total of 192 thyroid nodules in 188 patients (mean age: 50·2 ± 11·8 years) that had been initially diagnosed as AUS/ FLUS on US-guided fine needle aspiration ( US- FNA) were included. One cytopathologist retrospectively reviewed the cytology slides, subcategorizing cytology results into AUS and FLUS. A TIRADS category was assigned to each thyroid nodule according to the number of suspicious US features. Clinical, US features and malignancy rates were compared between the two subcategories. Results Of the 192 AUS/ FLUS lesions, 149 (77·6%) were subcategorized as AUS and 43 (22·4%) as FLUS. Of the 192 AUS/ FLUS nodules, 82 (42·7%) were malignant. The malignancy rates between AUS and FLUS subcategories were not significantly different, 45·6% to 32·6%, respectively ( P = 0·127). When applying TIRADS, significant differences were seen in TIRADS category between benign and malignant nodules in the AUS subcategory ( P < 0·001), but not in the FLUS subcategory ( P = 0·414). The malignancy rates in TIRADS categories 3, 4a, 4b, 4c and 5 were 15·4%, 22·2%, 33·3%, 57·1% and 80·0% ( P < 0·001) in AUS nodules and 40·0%, 50·0%, 23·5%, 22·2% and 0·0% ( P = 0·414) in FLUS nodules, respectively. Conclusion Suspicious US features are useful in predicting malignancy among AUS subcategories but not in FLUS subcategories. Subcategorization into AUS and FLUS cytology may be helpful in deciding upon treatment or management of thyroid nodules. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Value of additional von Kossa staining in thyroid nodules with echogenic spots on ultrasound.
- Author
-
Chae, In Hye, Kwon, Hyeong Ju, Kim, Eun-Kyung, Moon, Hee Jung, Yoon, Jung Hyun, Lee, Hye Sun, and Kwak, Jin Young
- Subjects
- *
THYROID gland physiology , *ULTRASONIC imaging , *STAINS & staining (Microscopy) , *LYMPH node cancer , *METASTASIS - Abstract
Purpose To evaluate the clinical value of additional von Kossa staining on cytology in thyroid nodules with echogenic spots on ultrasound (US). Materials and methods 342 thyroid nodules were analyzed for cytology and von Kossa staining was performed to detect microcalcifications. We compared diagnostic performances and accuracies of FNA and FNA with von Kossa staining to detect malignancy. We evaluated associations of aggressive pathologic features and von Kossa positivity in the surgically confirmed papillary thyroid carcinoma (PTC) group. Results Two hundred and thirty two (67.8%) nodules were malignant and 110 (32.2%) were benign on cytopathology. Compared to cytology alone, additional von Kossa staining slightly improved sensitivity from 89.7% to 90.9% ( P = 0.081). In 207 cases of surgically confirmed PTC, von Kossa positivity was an independent predictor of central lymph node metastasis in PTCs by multivariate analysis (odds ratio, 2.218; P = 0.021). Conclusions Adding von Kossa staining to cytology improved the sensitivity of thyroid nodules with echogenic spots on US. Positive von Kossa stains in PTCs may also be useful in predicting central lymph node metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
25. Cytomorphologic features in thyroid nodules read as “suspicious for malignancy” on cytology may predict thyroid cancers with the BRAF mutation.
- Author
-
Kwon, Hyeong Ju, Kim, Eun-Kyung, and Kwak, Jin Young
- Subjects
- *
THYROID cancer , *CYTOLOGY , *GENETIC mutation , *CELLULAR pathology , *CELL morphology , *NEEDLE biopsy - Abstract
Some morphologic parameters have been studied to help predict the BRAF V600E mutation using cytopathologic specimens, which can indicate which nodules should undergo further testing. The aim of this study was to investigate the value of cytomorphologic parameters to predict the BRAF V600E mutation in nodules read as “suspicious for malignancy” on cytology. This study included 142 resected nodules which were diagnosed as “suspicious for malignancy” on cytology in 142 patients. At our institution, BRAF V600E mutation analysis was performed at the request of the referring clinicians based on the clinical features of the patients, or the judgment of the radiologists performing US-FNA because suspicious US features were observed on the targeted nodule during this study period. Cytology smears were re-reviewed to assess the presence and amount of polygonal eosinophilic (plump) cells and microfollicles, and the presence of intranuclear pseudoinclusions, irregular nuclear membranes, nuclear grooves, sickles cells, psammoma bodies, and cystic changes. We evaluated the diagnostic performances of the cytomorphologic features to predict the BRAF V600E mutation. Polygonal eosinophilic (plump) cells, microfollicles, intranuclear pseudoinclusions, sickle cells, and cystic changes were significantly associated with the BRAF V600E mutation. The mutation was not present in all 6 thyroid nodules with microfollicles larger than 20% on cytology. Additionally, polygonal eosinophilic (plump) cells larger than 20%, cystic changes, and sickle cells on cytology had a high specificity of 95%, 96.7%, and 81.7%, respectively. Excluding 6 nodules with microfollicles larger than 20% on cytology, there were 82 (60.3%) nodules with the BRAF V600E mutation among the 136 nodules. Among the 136 nodules, there were 95 nodules with polygonal eosinophilic (plump) cells larger than 20%, cystic changes, or sickle cells on cytology. Of the 95 nodules, 69 (72.6%) had the mutation. Cytomorphologic features can help select nodules for the BRAF V600E mutation test among nodules read as “suspicious for malignancy” on cytology. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
26. Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas.
- Author
-
Choi, Euno, Byeon, Sun-ju, Kim, Soo Hee, Lee, Hyun Ju, Kwon, Hyeong Ju, Ahn, HyeSeong, Kim, Dong Ha, and Chang, Mee Soo
- Subjects
LEPTIN ,CELLULAR signal transduction ,EPSTEIN-Barr virus ,STOMACH cancer ,IMMUNOHISTOCHEMISTRY - Abstract
We investigated the clinicopathological implications of leptin-signaling proteins and Epstein-Barr virus (EBV)-infection status in gastric carcinomas. Immunohistochemistry for leptin signalling-related proteins (leptin, leptin-receptor, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha), and in situ hybridization for EBV-encoded small RNAs was performed in 343 cases of gastric carcinomas. The siRNA against leptin-receptor was transfected into three stomach cancer cell lines, and western blot for caspase 3 was performed. The TNM stage was a prognostic factor in all 343 patients, and was negatively correlated with expression of leptin, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha (P < 0.05). Leptin-receptor expression was correlated with poor survival in 207 patients of the advanced gastric cancer (AGC) subgroup, 139 of the Lauren diffuse group, and in 160 patients with lymph node metastasis (P < 0.05, respectively). Additionally, in stomach cancer cells, cleaved caspase 3 level increased by leptin-receptor inhibition, that is, apoptosis increased. Interestingly, EBV-positive AGC (n = 29) tended to show better survival of patients than EBV-negative AGC (n = 178) (P = 0.06). pAkt expression was related with a good survival of 32 patients (9%) in the EBV-positive subgroup, but was not an independent prognostic factor. Among, leptin signaling-related proteins, expressions of leptin-receptor and mTOR were different between EBV-positive subgroup and EBV-negative subgroup (P < 0.05, respectively). In conclusion, leptin-signaling proteins and EBV status show different significance on patient survival, according to subsets of gastric carcinomas. The leptin-receptor may predict poor patient prognosis in the AGC, Lauren diffuse and lymph node metastasis subgroups, while EBV-positive status can show a good prognosis in the AGC. Each leptin signaling-related protein may be differently involved in carcinogenesis of EBV-negative and EBV-positive subsets. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
27. Ex Vivo Estimation of Photoacoustic Imaging for Detecting Thyroid Microcalcifications.
- Author
-
Kang, Jeeun, Chung, Woong Youn, Kang, Sang-Wook, Kwon, Hyeong Ju, Yoo, Jaeheung, Kim, Eun-Kyung, Chang, Jin Ho, Song, Tai-kyong, Lee, Sohee, and Kwak, Jin Young
- Subjects
PHOTOACOUSTIC detectors ,THYROID disease diagnosis ,CALCIFICATION ,ULTRASONIC imaging ,MEDICAL sciences - Abstract
Background: The aim of this study was to evaluate the diagnostic utility of PAI at detecting thyroid microcalcifications at 700 nm laser wavelengths. Methods: This study included 36 resected samples in 18 patients. To evaluate the PA manifestation of microcalcifications in PAI, gray level histogram and co-occurrence matrix (COM) texture parameters were extracted from the 3 fixed ROI US and PA images, respectively, per sample. We compared the textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without microcalcifications. Results: On specimen US, the mean value (2748.4±862.5) of samples with microcalcifications on specimen radiography was higher than that (1961.9±780.2) of those without microcalcifications (P = 0.007). However, there were no significant differences in textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without when applying both the mean value of the three slices of thyroid specimens and the value of the thyroid specimen slice which had the highest value of the mean values in specimen US. Conclusion: PAI did not show significant PA contrast on thyroid microcalcifications indicating that the experimental setup and protocols should be enhanced, e.g., method of complete blood rejection from ex vivo specimens, the multi-wavelength spectroscopic PA imaging method which can solely extract the PA signal from microcalcifications even with high spectral interferences, or PA imaging with narrower slice thickness using 2-dimensional array transducer, etc. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Expression of CD9 and CD82 in clear cell renal cell carcinoma and its clinical significance.
- Author
-
Kwon, Hyeong Ju, Min, Sun Young, Park, Min Jee, Lee, Cheol, Park, Jeong Hwan, Chae, Ji Youn, and Moon, Kyung Chul
- Subjects
- *
CD9 antigen , *RENAL cell carcinoma , *GENE expression , *TETRASPANIN , *METASTASIS , *IMMUNOHISTOCHEMISTRY - Abstract
Abstract: CD9 and CD82, members of the tetraspanin family, act as metastasis suppressors in many human malignant tumors, but the role of these molecules is not well known in clear cell renal cell carcinoma (CCRCC). This study was designed to evaluate the immunohistochemical expression of CD9 and CD82 in 644 cases of CCRCC and to determine the clinicopathologic and prognostic significance of their expression. The percentage of positive tumor cells was evaluated, and the expression was classified into 2 categories: low expression (less than 10% positive cells) or high expression (more than 10% positive cells) for CD9 expression and negative (no positive cells) or positive for CD82 expression. CD9 high expression was found in 303 (47.0%) patients, and CD82 positivity was found in 98 (15.2%) patients. High expression of CD9 was statistically associated with older patients (p =0.003). The cases showing positive immunoreactivity for CD82 exhibited a high stage (p <0.001) and high nuclear grade (p <0.001). The overall, cancer-specific and progression-free survival rates were significantly higher in patients with a CD82-negative profile compared to patients with a CD82-positive profile (p <0.001). Although the biological function of CD82 in CCRCC remains unclear, the CCRCC patients with CD82 positive expression show poor prognosis. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
29. Clinicopathological features of severe forms of low gamma-glutamyltranspeptidase familial intrahepatic cholestasis in Korean pediatric patients.
- Author
-
Kwon, Hyeong Ju, Go, Heounjeong, Kim, Soo Hee, Ko, Jae Sung, Seo, Jeong Kee, and Kang, Gyeong Hoon
- Subjects
- *
JUVENILE diseases , *CHOLESTASIS , *CIRRHOSIS of the liver , *LIVER cells - Abstract
ABSTRACT Background and aim: Low gamma-glutamyltranspeptidase (γ-GTP) familial intrahepatic cholestasis is a broad-spectrum condition that ranges from mild to severe. Severe forms of low γ-GTP familial intrahepatic cholestasis, including progressive familial intrahepatic cholestasis type-1 and -2 (PFIC-1 and PFIC-2), present with symptoms of cholestasis early in life and may progress to cirrhosis. Methods: We included five patients with low γ-GTP, cholestasis and hyperbilirubinemia. We analyzed clinicopathological features of these five cases. Results: The age of the patients at diagnosis ranged from 1 month to 1 year old. All patients presented with jaundice, and one experienced pruritus. In contrast to hyperbilirubinemia, serum γ-GTP levels were relatively low, or within normal range. Microscopically, intracanalicular cholestasis, bile duct loss or atrophy and varying degrees of fibrosis were found in all of the cases, whereas giant cell formation of hepatocytes was detected in three cases. Anti-ABCB11 immunostaining revealed loss of expression in three cases with diffuse giant cell transformation of hepatocytes but retained expression in one case with no giant cell transformation. Conclusions: Low γ-GTP familial intrahepatic cholestasis (PFIC-1 and PFIC-2) should be considered a differential diagnosis when pediatric patients with cholestatic liver diseases associated with normal to low serum γ-GTP levels relative to the extent of cholestasis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
30. ORIGINAL ARTICLE: Expression pattern of glypican-3, HSP70, and glutamine synthetase in chronic hepatitis B and hepatocellular carcinoma.
- Author
-
Kim, Soo Hee, Lee, Kyoung Bun, Kwon, Hyeong-Ju, and Jang, Ja-June
- Subjects
HEPATITIS B ,GLUTAMINE synthetase ,GLYPICANS ,LIVER cancer ,NEEDLE biopsy ,LIVER cells ,BIOMARKERS ,HEAT shock proteins - Abstract
ABSTRACT Background and aim: The three-panel marker, glypican-3, HSP70 and glutamine synthetase, is helpful for making a diagnosis of early hepatocellular carcinoma. To further characterize the diagnostic values of these three markers, we performed immunostaining studies in non-neoplastic hepatocytes (chronic hepatitis B) and hepatocellular carcinoma. Methods: Immunostaining was performed for all three markers. The cases were 60 needle biopsies of chronic hepatitis B (30 with low-grade activity and 30 with high-grade activity) and 40 hepatocellular carcinomas (HCCs). Results: Glypican-3 staining was detected in only one of the 60 chronic hepatitis B cases, and this case expressed moderate immunoreactivity for glypican-3 and showed high-grade inflammatory activity. HSP70 expression was not observed in any cases. Glutamine synthetase was strongly immunoreactive at peri-venular hepatocytes with cytoplasmic staining in all cases. These findings reflected a normal expression pattern. On the other hand, all three markers were positive in 15 (37.5%) HCCs. At least two of three markers were positive in 26 (65.0%). Moreover, all three markers were negative in 2 (5.0%) HCCs. Conclusions: The combination of these three markers is highly specific for detecting hepatocellular carcinoma. However, caution should be exercised because non-neoplastic hepatocytes in chronic hepatitis B with high necro-inflammatory activity tend to show focal positivity for glypican-3. Also we emphasize that all three markers can show negative immunoreactivity in HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
31. Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.
- Author
-
Huang, Kie Kyon, Jang, Kang Won, Kim, Sangwoo, Kim, Han Sang, Kim, Sung-Moo, Kwon, Hyeong Ju, Kim, Hye Ryun, Yun, Hwan Jung, Ahn, Myung Ju, Park, Keon Uk, Ramnarayanan, Kalpana, McPherson, John R., Zhang, Shenli, Rhee, Je-Keun, Vettore, André L., Das, Kakoli, Ishimoto, Takatsugu, Kim, Joo Hang, Koh, Yoon Woo, and Kim, Se Hun
- Published
- 2016
- Full Text
- View/download PDF
32. RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?
- Author
-
Yoon, Jung Hyun, Kwon, Hyeong Ju, Lee, Hye Sun, Kim, Eun-Kyung, Moon, Hee Jung, and Kwak, Jin Young
- Published
- 2015
- Full Text
- View/download PDF
33. Fine Needle Aspiration Cytology vs. Core Needle Biopsy for Thyroid Nodules: A Prospective, Experimental Study Using Surgical Specimen.
- Author
-
Kwon H, Lee J, Hong SW, Kwon HJ, Kwak JY, and Yoon JH
- Abstract
Purpose: To evaluate and compare the diagnostic outcomes of ultrasonography (US)-guided fine needle aspiration (FNA) and core needle biopsy (CNB) performed on the same thyroid nodule using a surgical specimen for direct comparison., Materials and Methods: We included 89 thyroid nodules from 88 patients from February 2015 to January 2016. The inclusion criterion was thyroid nodules measuring ≥ 20 mm (mean size: 40.0 ± 15.3 mm). Immediately after surgical resection, FNA and subsequent CNB were performed on the surgical specimen under US guidance. FNA and CNB cytopathologic results on the specimen were compared with the surgical diagnosis., Results: Among the 89 nodules, 30 were malignant and 59 were benign. Significantly higher inconclusive rates were seen in FNA for malignant than benign nodules (80.0% vs. 39.0%, p < 0.001). For CNB, conclusive and inconclusive rates did not differ between benign and malignant nodules ( p = 0.796). Higher inconclusive rates were seen for FNA among cancers regardless of US features, and in the subgroup of size ≥ 40 mm (62.5% vs. 22.9%, p = 0.028). Eleven cancers were diagnosed with CNB (36.7%, 11/30), while none was diagnosed using FNA., Conclusion: In this experimental study using surgical specimens, CNB showed a potential to provide improved diagnostic sensitivity for thyroid cancer, especially when a conclusive diagnosis is limited with FNA., Competing Interests: Conflicts of Interest: The authors have no potential conflicts of interest to disclose., (Copyrights © 2022 The Korean Society of Radiology.)
- Published
- 2022
- Full Text
- View/download PDF
34. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer.
- Author
-
Lee J, Kim CH, Min IK, Jeong S, Kim H, Choi MJ, Kwon HJ, Jung SG, and Jo YS
- Subjects
- Adult, Female, Humans, Lymph Nodes pathology, Male, Middle Aged, Neoplasm Recurrence, Local diagnosis, Retrospective Studies, Risk Assessment, Risk Factors, Lymphatic Metastasis diagnosis, Lymphatic Metastasis pathology, Thyroid Cancer, Papillary diagnosis, Thyroid Cancer, Papillary pathology, Thyroid Neoplasms diagnosis, Thyroid Neoplasms pathology
- Abstract
Objective: The characteristics of metastatic lymph nodes (MLNs) have been investigated as important predictors of recurrence and progression in papillary thyroid cancer (PTC). However, clinically applicable risk stratification systems are limited to the assessment of size and number of MLNs. This study investigated the predictive value of detailed characteristics of MLNs in combination with currently used risk stratification systems., Design and Methods: We retrospectively characterized 2811 MLNs from 9014 harvested LNs of 286 patients with N1 PTC according to the maximum diameter of MLN (MDLN), maximum diameter of metastatic focus (MDMF), ratio of both diameters (MDMFR), lymph node ratio (LNR, number of MLNs/number of total harvested LNs), presence of extranodal extension (ENE), desmoplastic reaction (DR), cystic component, and psammoma body., Results: Factors related to the size and number of MLNs were associated with increased risk of recurrence and progression. Extensive presence of ENE (>40%) and DR (≥50%) increased the risk of recurrence/progression. The combination of MDLN, LNR, ENE, and DR had the highest predictive value among MLN characteristics. Combination of these parameters with ATA risk stratification or 1-year response to therapy improved the predictive power for recurrence/progression from a Harrell's C-index of 0.781 to 0.936 and 0.867 to 0.960, respectively., Conclusions: The combination of currently used risk stratification systems with detailed characterization of MLNs may improve the predictive accuracy for recurrence/progression in N1 PTC patients.
- Published
- 2020
- Full Text
- View/download PDF
35. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
- Author
-
Das R, Kim SJ, Nguyen NT, Kwon HJ, Cha SK, and Park KS
- Subjects
- Animals, Cell Line, Disease Models, Animal, Doxorubicin toxicity, Drug Evaluation, Preclinical, Glomerulosclerosis, Focal Segmental chemically induced, Glomerulosclerosis, Focal Segmental pathology, Humans, Kidney Glomerulus drug effects, Kidney Glomerulus pathology, Male, Mechanistic Target of Rapamycin Complex 1 metabolism, Mice, Phosphorylation drug effects, Proteinuria chemically induced, Proteinuria pathology, Pyridones therapeutic use, Pyrimidinones therapeutic use, Rats, Glomerulosclerosis, Focal Segmental drug therapy, MAP Kinase Signaling System drug effects, Proteinuria drug therapy, Pyridones pharmacology, Pyrimidinones pharmacology, Transforming Growth Factor beta metabolism
- Abstract
Transforming growth factor-β (TGF-β) plays crucial roles in the development of focal segmental glomerulosclerosis, but key molecular pathways remain unknown. Here, we identified the regulation of mammalian target of rapamycin complex1 (mTORC1) by TGF-β via ERK1/2 in the Adriamycin-induced murine model of focal segmental glomerulosclerosis. Adriamycin administration elicited early activation of TGF-β-ERK1/2-mTORC1 in podocytes, which persisted at later stages of albuminuria and glomerulosclerosis. Phosphorylation of the TGF-β receptor-I (TGF-βRI), Smad3, ERK1/2 and ribosomal protein S6 were evident in the glomeruli of adriamycin-treated mice. Targeting TGFβ-RI and mTORC1 with pharmacological inhibitors suppressed TGF-β signaling in glomeruli and significantly reduced albuminuria, glomerulosclerosis, protein levels of collagen 4α3, plasminogen activator inhibitor-1, and vimentin and restored mRNA levels of podocyte markers. Low dose US Food and Drug Administration (FDA)-approved MEK/ERK inhibitor trametinib/GSK1120212 blunted TGF-β1-induced mTORC1 activation in podocytes, ameliorated up-regulation of TGF-β, plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, fibronectin and α-smooth muscle actin and prevented albuminuria and glomerulosclerosis with improved serum albumin. In cultured podocytes, this pathway was found to be associated with translation of fibrogenic collagen 4α3 and plasminogen activator inhibitor-1, without influencing their transcription. Notably, rapamycin suppressed upstream p-TGF-βRI, p-Smad3 and p-ERK1/2, and trametinib down-regulated upstream p-Smad3 in ex vivo and in vivo studies, indicating that harmful paracrine signaling among glomerular cells amplified the TGF-β-ERK1/2-mTORC1 axis by forming a positive feedback loop. Thus, an accentuated TGF-β-ERK1/2-mTORC1 pathway is suggested as a central upstream mediator to develop proteinuria and glomerulosclerosis. Hence, preventing activation of this vicious loop by trametinib may offer a new therapeutic strategy for glomerular disease treatment., (Copyright © 2019 International Society of Nephrology. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
36. Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line.
- Author
-
Lim JS, Eom YW, Lee ES, Kwon HJ, Kwon JY, Choi J, Chung CH, Jo YS, and Lee EJ
- Subjects
- ACTH-Secreting Pituitary Adenoma genetics, Adenoma genetics, Animals, Cell Line, Tumor, Cell Survival drug effects, Gene Expression drug effects, MAP Kinase Signaling System drug effects, Mice, Pro-Opiomelanocortin metabolism, Proliferating Cell Nuclear Antigen metabolism, Rats, Receptors, Oxytocin metabolism, ACTH-Secreting Pituitary Adenoma metabolism, Adenoma metabolism, Cell Proliferation drug effects, Oxytocin pharmacology
- Abstract
Background: Oxytocin (OXT) has been reported to act as a growth regulator in various tumor cells. However, there is a paucity of data on the influence of OXT on cell proliferation of corticotroph adenomas. This study aimed to examine whether OXT affects cell growth in pituitary tumor cell lines (AtT20 and GH3 cells) with a focus on corticotroph adenoma cells., Methods: Reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay were conducted with AtT20 cells to confirm the effects of OXT on hormonal activity; flow cytometry was used to assess changes in the cell cycle after OXT treatment. Moreover, the impact of OXT on proliferating cell nuclear antigen (PCNA), nuclear factor κB, and mitogen-activated protein kinase signaling pathway was analyzed by Western blot., Results: OXT treatment of 50 nM changed the gene expression of OXT receptor and pro-opiomelanocortin within a short time. In addition, OXT significantly reduced adrenocorticotropic hormone secretion within 1 hour. S and G2/M populations of AtT20 cells treated with OXT for 24 hours were significantly decreased compared to the control. Furthermore, OXT treatment decreased the protein levels of PCNA and phosphorylated extracellular-signal-regulated kinase (P-ERK) in AtT20 cells., Conclusion: Although the cytotoxic effect of OXT in AtT20 cells was not definite, OXT may blunt cell proliferation of corticotroph adenomas by altering the cell cycle or reducing PCNA and P-ERK levels. Further research is required to investigate the role of OXT as a potential therapeutic target in corticotroph adenomas., Competing Interests: No potential conflict of interest relevant to this article was reported., (Copyright © 2019 Korean Endocrine Society.)
- Published
- 2019
- Full Text
- View/download PDF
37. Peripheral location and infiltrative margin predict invasive features of papillary thyroid microcarcinoma.
- Author
-
Lee WK, Lee J, Kim H, Lee SG, Choi SH, Jeong S, Kwon HJ, Jung SG, and Jo YS
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Neoplasm Invasiveness pathology, Predictive Value of Tests, Carcinoma, Papillary pathology, Carcinoma, Papillary surgery, Lymphatic Metastasis pathology, Margins of Excision, Thyroid Neoplasms pathology, Thyroid Neoplasms surgery
- Abstract
Objective: Tumor location in papillary thyroid microcarcinoma (PTMC) might determine tumor outgrowth from the thyroid gland. However, the clinical implications of tumor location and minimal extrathyroid extension (mETE) have not been well elucidated. We aimed to investigate the relationship between tumor location and mETE to predict the aggressiveness of PTMC., Methods: A total of 858 patients with PTMC were grouped according to tumor location on ultrasonography: central (cPTMC) and peripheral PTMC (pPTMC). PTMC without mETE (PTMC-mETE(-)) was divided further according to margin shape: encapsulated (E-) or infiltrative (I-). To understand the molecular biologic characteristics of PTMC presenting with an I-margin and mETE, transcriptome data from TCGA-THCA were analyzed using Gene Set Enrichment Analysis (GSEA)., Results: pPTMC (n = 807, 94.1%) accounted for the majority of cases; mETE was identified only in pPTMC (403/807; 49.9%). pPTMC-mETE(+) showed aggressive clinical characteristics that increased the odds ratio (OR) for lymph node metastasis (LNM). Interestingly, subgroup analysis of PTMC-mETE(-) revealed that the I-margin also increased the OR for LNM, independent of other clinical factors. GSEA of TCGA-THCA data suggested coordinated upregulation of genes related to epithelial-mesenchymal transition (EMT) in PTC with mETE. Immunohistochemical staining for laminin subunit gamma 2 (LAMC2), CD59, E-cadherin and vimentin showed that these markers of EMT were associated with progressive changes in E-margin PTMC-mETE(-), I-margin PTMC-mETE(-) and pPTMC-mETE(+)., Conclusion: mETE related to peripheral location of PTMC is an important predictor of tumor invasiveness, as is the I-margin, which presents with EMT features similar to mETE. I-margin PTMC-mETE(-) and pPTMC-mETE(+) might reflect the pattern of invasive PTMC.
- Published
- 2019
- Full Text
- View/download PDF
38. Expression of CD9 and CD82 in papillary thyroid microcarcinoma and its prognostic significance.
- Author
-
Kim T, Kim Y, and Kwon HJ
- Subjects
- Adult, Carcinoma, Papillary genetics, Carcinoma, Papillary metabolism, Carcinoma, Papillary surgery, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Thyroid Neoplasms genetics, Thyroid Neoplasms metabolism, Thyroid Neoplasms surgery, Thyroidectomy, Carcinoma, Papillary diagnosis, Gene Expression Regulation, Neoplastic, Kangai-1 Protein genetics, Tetraspanin 29 genetics, Thyroid Neoplasms diagnosis
- Abstract
Introduction: papillary thyroid microcarcinoma is a well-known malignant neoplasm with good prognosis. The known prognostic factors are patient's age, multifocality, and extrathyroidal extension. CD9 and CD82, members of the tetraspanin family, are expressed in numerous cancer cells and play many roles associated with the cellular process., Material and Methods: we investigated the immunohistochemical expression of CD9 and CD82 in papillary thyroid microcarcinoma and analysed the clinicopathological and prognostic significance. For the retrospective analysis, we collected the cases of 553 PTMC patients who had undergone thyroidectomy., Results: The group with lymph node metastasis showed higher immunostaining intensity for CD9 than the group without metastasis (p = 0.002). In multivariate analysis, high CD9 intensity (OR = 1.58 in 3+, p = 0.0025) correlated with lymph node metastasis., Conclusion: We suggest CD9 as a predictive prognostic factor for lymph node metastasis in PTMC.
- Published
- 2019
- Full Text
- View/download PDF
39. Thyroid Fine-Needle Aspiration Cytology Practice in Korea.
- Author
-
Cha YJ, Pyo JY, Hong S, Seok JY, Kim KJ, Han JY, Bae JM, Kwon HJ, Kim Y, Min KW, Oak S, and Chang S
- Abstract
We reviewed the current status of thyroid fine-needle aspiration cytology (FNAC) in Korea. Thyroid aspiration biopsy was first introduced in Korea in 1977. Currently, radiologists aspirate the thyroid nodule under the guidance of ultrasonography, and cytologic interpretation is only legally approved when a cytopathologist makes the diagnosis. In 2008, eight thyroid-related societies came together to form the Korean Thyroid Association. The Korean Society for Cytopathology and the endocrine pathology study group of the Korean Society for Pathologists have been updating the cytologic diagnostic guidelines. The Bethesda System for Reporting Thyroid Cytopathology was first introduced in 2009, and has been used by up to 94% of institutions by 2016. The average diagnosis rates are as follows for each category: I (12.4%), II (57.9%), III (10.4%), IV (2.9%), V (3.7%), and VI (12.7%). The malignancy rates in surgical cases are as follows for each category: I (28.7%), II (27.8%), III (50.6%), IV (52.3%), V (90.7%), and VI (100.0%). Liquid-based cytology has been used since 2010, and it was utilized by 68% of institutions in 2016. The categorization of thyroid lesions into "atypia of undetermined significance" or "follicular lesion of undetermined significance" is necessary to draw consensus in our society. Immunocytochemistry for galectin-3 and BRAF is used. Additionally, a molecular test for BRAF in thyroid FNACs is actively used. Core biopsies were performed in only 44% of institutions. Even the institutions that perform core biopsies only perform them for less than 3% of all FNACs. However, only 5% of institutions performed core biopsies up to three times more than FNAC.
- Published
- 2017
- Full Text
- View/download PDF
40. Bronchial Washing Cytology of Pulmonary Langerhans Cell Histiocytosis: A Case Report.
- Author
-
Kim T, Kwon HJ, Eom M, Kim SW, Sin MH, and Jung SH
- Published
- 2017
- Full Text
- View/download PDF
41. The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists.
- Author
-
Kim M, Park HJ, Min HS, Kwon HJ, Jung CK, Chae SW, Yoo HJ, Choi YD, Lee MJ, Kwak JJ, Song DE, Kim DH, Lee HK, Kim JY, Hong SH, Sohn JS, Lee HS, Park SY, Hong SW, and Shin MK
- Abstract
Background: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has standardized the reporting of thyroid cytology specimens. The objective of the current study was to evaluate the nationwide usage of TBSRTC and assess the malignancy rates in each category of TBSRTC in Korea., Methods: Questionnaire surveys were used for data collection on the fine needle aspiration (FNA) of thyroid nodules at 74 institutes in 2012. The incidences and follow-up malignancy rates of each category diagnosed from January to December, 2011, in each institute were also collected and analyzed., Results: Sixty out of 74 institutes answering the surveys reported the results of thyroid FNA in accordance with TBSRTC. The average malignancy rates for resected cases in 15 institutes were as follows: nondiagnostic, 45.6%; benign, 16.5%; atypical of undetermined significance, 68.8%; suspicious for follicular neoplasm (SFN), 30.2%; suspicious for malignancy, 97.5%; malignancy, 99.7%., Conclusions: More than 80% of Korean institutes were using TBSRTC as of 2012. All malignancy rates other than the SFN and malignancy categories were higher than those reported by other countries. Therefore, the guidelines for treating patients with thyroid nodules in Korea should be revisited based on the malignancy rates reported in this study.
- Published
- 2017
- Full Text
- View/download PDF
42. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
- Author
-
Choi YS, Park M, Kwon HJ, Koh YW, Lee SK, and Kim J
- Subjects
- Aged, Biomarkers, Tumor analysis, Biomarkers, Tumor isolation & purification, Biomarkers, Tumor metabolism, Contrast Media, Female, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Male, Middle Aged, Mouth chemistry, Mouth pathology, Mouth virology, Retrospective Studies, Carcinoma, Squamous Cell chemistry, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell virology, ErbB Receptors metabolism, Mouth Neoplasms chemistry, Mouth Neoplasms metabolism, Mouth Neoplasms pathology, Mouth Neoplasms virology, Oropharyngeal Neoplasms chemistry, Oropharyngeal Neoplasms metabolism, Oropharyngeal Neoplasms pathology, Oropharyngeal Neoplasms virology, Papillomaviridae isolation & purification
- Abstract
Objective: The objective of this study was to investigate differences in dynamic contrast-enhanced MRI (DCE-MRI) parameters on the basis of the status of human papillomavirus (HPV) and epidermal growth factor receptor (EGFR) biomarkers in patients with squamous cell carcinoma (SCC) of the oral cavity and oropharynx by use of histogram analysis., Materials and Methods: A total of 22 consecutive patients with oral cavity and oropharyngeal SCC underwent DCE-MRI before receiving treatment. DCE parameter maps of the volume transfer constant (K(trans)), the flux rate constant (kep), and the extravascular extracellular volume fraction (ve) were obtained. The histogram parameters were calculated using the entire enhancing tumor volume and were compared between the patient subgroups on the basis of HPV and EGFR biomarker statuses., Results: The cumulative histogram parameters of K(trans) and kep showed lower values in the HPV-negative and EFGR-overexpression group than in the HPV-positive EGFR-negative group. These differences were statistically significant for the mean (p = 0.009), 25th, 50th, and 75th percentile values of K(trans) and for the 25th percentile value of kep when correlated with HPV status in addition to the mean K(trans) value (p = 0.047) and kep value (p = 0.004) when correlated with EGFR status. No statistically significant difference in ve was found on the basis of HPV and EGFR status., Conclusion: DCE-MRI is useful for the assessment of the tumor microenvironment associated with HPV and EGFR biomarkers before treatment of patients with oral cavity and oropharyngeal SCC.
- Published
- 2016
- Full Text
- View/download PDF
43. The follicular variant of papillary thyroid carcinoma: characteristics of preoperative ultrasonography and cytology.
- Author
-
Yoon JH, Kwon HJ, Kim EK, Moon HJ, and Kwak JY
- Abstract
Purpose: The goal of this study was to validate the ultrasonography (US) and cytopathological features that are used in the diagnosis of the follicular variant of papillary thyroid carcinoma (FVPTC) and to characterize the role of BRAF (V600E) mutation analysis in the diagnosis of FVPTC., Methods: From May 2012 to February 2014, 40 thyroid nodules from 40 patients (mean age, 56.2 years; range, 26 to 81 years) diagnosed with FVPTC were included in this study. The US features of the nodules were analyzed and the nodules were classified as probably benign or suspicious for malignancy. Twenty-three thyroid nodules (57.5%) underwent BRAF (V600E) mutation analysis. Clinical information and histopathologic results were obtained by reviewing the medical records of the patients., Results: Thirty nodules (75.0%) were classified as suspicious for malignancy, while 10 (25.0%) were classified as probably benign. Seven of the eight nodules (87.5%) with atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) cytology showed suspicious US features, while one of the two nodules (50.0%) with follicular neoplasm cytology presented suspicious US features. Five of the 23 nodules (21.7%) that underwent BRAF (V600E) mutation analysis had positive results, all of which were diagnosed as suspicious for malignancy or malignant based on cytology. None of the nodules with benign, AUS/FLUS, or follicular neoplasm cytology were positive for the BRAF (V600E) mutation., Conclusion: US features allow nodules to be classified as suspicious for malignancy, and the presence of suspicious US features in nodules with ambiguous cytology may aid in the diagnosis of FVPTC. BRAF (V600E) mutation analysis is of limited value in the diagnosis of FVPTC.
- Published
- 2016
- Full Text
- View/download PDF
44. Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1α.
- Author
-
Yang YJ, Na HJ, Suh MJ, Ban MJ, Byeon HK, Kim WS, Kim JW, Choi EC, Kwon HJ, Chang JW, and Koh YW
- Subjects
- Adenocarcinoma, Follicular metabolism, Animals, Cadherins genetics, Gene Expression Regulation, Neoplastic, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Lymphokines, Mice, Neoplasm Invasiveness, Phenotype, Real-Time Polymerase Chain Reaction, Signal Transduction drug effects, Thyroid Neoplasms metabolism, Transcriptional Activation, Twist-Related Protein 1 metabolism, Vimentin metabolism, Adenocarcinoma, Follicular genetics, Epithelial-Mesenchymal Transition genetics, Hypoxia genetics, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Thyroid Neoplasms genetics, Twist-Related Protein 1 genetics
- Abstract
Purpose: Although follicular thyroid cancer (FTC) has a relatively fair prognosis, distant metastasis sometimes results in poor prognosis and survival. There is little understanding of the mechanisms contributing to the aggressiveness potential of thyroid cancer. We showed that hypoxia inducible factor-1α (HIF-1α) induced aggressiveness in FTC cells and identified the underlying mechanism of the HIF-1α-induced invasive characteristics., Materials and Methods: Cells were cultured under controlled hypoxic environments (1% O₂) or normoxic conditions. The effect of hypoxia on HIF-1α, and epithelial-to-mesenchymal transition (EMT) related markers were evaluated by quantitative real-time PCR, Western blot analysis and immunocytochemistry. Invasion and wound healing assay were conducted to identify functional character of EMT. The involvement of HIF-1α and Twist in EMT were studied using gene overexpression or silencing. After orthotopic nude mouse model was established using the cells transfected with lentiviral shHIF-1α, tissue analysis was done., Results: Hypoxia induces HIF-1α expression and EMT, including typical morphologic changes, cadherin shift, and increased vimentin expression. We showed that overexpression of HIF-1α via transfection resulted in the aforementioned changes without hypoxia, and repression of HIF-1α with RNA interference suppressed hypoxia-induced HIF-1α and EMT. Furthermore, we also observed that Twist expression was regulated by HIF-1α. These were confirmed in the orthotopic FTC model., Conclusion: Hypoxia induced HIF-1α, which in turn induced EMT, resulting in the increased capacity for invasion and migration of cells via regulation of the Twist signal pathway in FTC cells. These findings provide insight into a possible therapeutic strategy to prevent invasive and metastatic FTC.
- Published
- 2015
- Full Text
- View/download PDF
45. Applying Ultrasound-Guided Core Needle Biopsy for Diagnosis of Thyroid Masses: Preliminary Results From a Single Institution.
- Author
-
Kim YH, Kwon HJ, Kim EK, Kwak JY, Moon HJ, and Yoon JH
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Observer Variation, Pilot Projects, Prevalence, Reproducibility of Results, Risk Assessment methods, Sensitivity and Specificity, Thyroid Nodule diagnostic imaging, Young Adult, Endoscopic Ultrasound-Guided Fine Needle Aspiration methods, Endoscopic Ultrasound-Guided Fine Needle Aspiration statistics & numerical data, Thyroid Nodule epidemiology, Thyroid Nodule pathology
- Abstract
Objectives: The purpose of this study was to investigate the level of conclusive results obtained with ultrasound (US)-guided core needle biopsy (CNB) and how this method should be applied for diagnosis of thyroid nodules., Methods: From January 2013 to November 2014, US-guided CNB was performed in 84 thyroid lesions of 83 patients. Based on CNB pathologic reports, thyroid nodules were divided into 2 categories: conclusive (nodules reaching a definite pathologic diagnosis suggesting benignity or malignancy) and inconclusive (nodules that were not able to reach a definite diagnosis because of ambiguous results). Medical records and US examinations were reviewed and compared., Results: The mean age of the 83 patients ± SD was 49.7 ± 14.1 years. Of the 84 thyroid nodules, 73 (86.9%) were diagnosed as benign or malignant and 11 (13.1%) as inconclusive by CNB pathologic analysis. Among the 11 nodules with inconclusive results, the possibility of a follicular neoplasm was suggested in 8 nodules (72.7%). No significant difference was seen in tumor size and US features when comparing the nodules with conclusive and inconclusive results (all P >.05)., Conclusions: Ultrasound-guided CNB may have supplemental roles in addition to US-guided fine-needle aspiration for diagnosis of selected cases. A considerable proportion of inconclusive results are seen on US-guided CNB, especially for diagnosis of follicular lesions, which must be considered when using this method for diagnosis of thyroid nodules., (© 2015 by the American Institute of Ultrasound in Medicine.)
- Published
- 2015
- Full Text
- View/download PDF
46. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
- Author
-
Lee J, Seol MY, Jeong S, Kwon HJ, Lee CR, Ku CR, Kang SW, Jeong JJ, Shin DY, Nam KH, Lee EJ, Chung WY, and Jo YS
- Subjects
- Carcinoma genetics, Carcinoma metabolism, Carcinoma pathology, Carcinoma, Papillary, Cell Line, Tumor, Cell Proliferation, Computational Biology, Gene Expression Regulation, Neoplastic, Humans, Mitochondria metabolism, Mitochondria ultrastructure, Mutation genetics, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Protein Kinases genetics, Proto-Oncogene Proteins B-raf genetics, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Small Interfering metabolism, Thyroid Cancer, Papillary, Thyroid Gland metabolism, Thyroid Gland pathology, Thyroid Neoplasms genetics, Thyroid Neoplasms pathology, Oxidative Phosphorylation, Protein Kinases metabolism, Receptors, Notch metabolism, Signal Transduction, Thyroid Neoplasms metabolism
- Abstract
Kinase suppressor of RAS1 (KSR1) is a scaffold protein implicated in RAS-mediated RAF activation. However, the molecular function of KSR in papillary thyroid cancer (PTC) is unknown. Thus, this study aimed to characterize the role of KSR1 in patients with PTC. qRT-PCR and immunohistochemistry (IHC) revealed inter-tumor heterogeneities in the expression of KSR1 in PTC tissues. Interestingly, BRAFV600E-positive PTC showed higher KSR1 mRNA expression than BRAFV600E-negative PTC (P<0.001). Gene Set Enrichment Analysis (GSEA) using public repositories showed that high KSR1 expression coordinately upregulated Notch signaling (nominal P=0.019, false discovery rate (FDR) q-value=0.165); this finding was supported by GeneNetwork analysis, indicating that KSR1 expression is positively correlated with NOTCH1 expression (ρ=0.677, P=6.15×10(-9)). siRNA against KSR1 (siKSR1) significantly decreased ERK phosphorylation induced by BRAFV600E, resulting in reduced expression of NOTCH1 and HES1, targets of Notch signaling. GSEA revealed that high KSR1 expression was also associated with downregulation of genes related to oxidative phosphorylation (OxPhos). Consistent with this, electron microscopy showed that PTCs with high KSR1 expression exhibited structural defects of the mitochondrial cristae. Furthermore, siKSR1-transfected BCPAP and 8505C cells generated fewer colonies in colony-forming assays. In addition, GSEA showed that high expression of KSR2 and connector enhancer of KSR1 (CNKSR1) also coordinately upregulated Notch signaling (KSR2: nominal P=0.0097, FDR q-value=0.154 and CNKSR1: nominal P<0.0001, FDR q-value=0.00554), and high CNKSR2 was associated with downregulation of the OxPhos gene set (nominal P<0.0001, FDR q-value <0.0001). In conclusion, KSR1 is coordinately regulated with Notch signaling and OxPhos in PTC, because its scaffold function might be required to sustain the proliferative signaling and metabolic remodeling associated with this type of cancer., (© 2015 Society for Endocrinology.)
- Published
- 2015
- Full Text
- View/download PDF
47. Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.
- Author
-
Kim HS, Kwon HJ, Jung I, Yun MR, Ahn MJ, Kang BW, Sun JM, Kim SB, Yoon DH, Park KU, Lee SH, Koh YW, Kim SH, Choi EC, Koo DH, Sohn JH, Kim B, Kwon NJ, Yun HJ, Lee MG, Lee JH, Kim TM, Kim HR, Kim JH, Paik S, and Cho BC
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Agents administration & dosage, Antineoplastic Agents adverse effects, Biomarkers, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell mortality, Cluster Analysis, Female, Gene Dosage, Gene Expression Profiling, Head and Neck Neoplasms genetics, Head and Neck Neoplasms mortality, Humans, Male, Middle Aged, Mutation, Neoplasm Metastasis, Neoplasm Recurrence, Local, Prognosis, Protein Kinase Inhibitors administration & dosage, Protein Kinase Inhibitors adverse effects, Quinazolinones administration & dosage, Quinazolinones adverse effects, Retreatment, Risk Factors, Squamous Cell Carcinoma of Head and Neck, Treatment Outcome, Antineoplastic Agents therapeutic use, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell pathology, Head and Neck Neoplasms drug therapy, Head and Neck Neoplasms pathology, Protein Kinase Inhibitors therapeutic use, Quinazolinones therapeutic use
- Abstract
Purpose: The goals of this study were to investigate the clinical activity, safety, and biomarkers of dacomitinib, an irreversible tyrosine kinase inhibitor of EGFR, HER2, and HER4, in recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M-SCCHN)., Experimental Design: Patients were eligible if the diseases were not amenable to curative treatment and had progressed on platinum-based chemotherapy, and were treated with dacomitinib 45 mg/day. The primary endpoint was objective response rate by RECISTv1.1. Exploratory analysis included the characterization of somatic mutation, gene copy number, gene expression, p16(INK4A) expression by IHC, and investigation of their relationship with clinical outcomes., Results: Forty-eight patients were evaluable for efficacy and toxicity. Ten patients (20.8%) had partial responses and 31 patients (65%) had stable diseases. The median progression-free survival (PFS) and overall survival (OS) were 3.9 months [95% confidence interval (CI), 2.9-5.0] and 6.6 months (95% CI, 5.4-10.3). Adverse events were mostly grade 1-2. Mutations in the PI3K pathway (PIK3CA, PTEN) and high expression of inflammatory cytokines (IL6, IL8, IL1A, IL1B, IL4, and TNF) were significantly associated with shorter PFS (2.9 vs. 4.9 months without mutations, P = 0.013; 2.8 vs. 9.9 months with low expression, P = 0.004). Those harboring PI3K pathway mutations or high inflammatory cytokine expression had shorter median OS (6.1 vs. 12.5 months lacking PI3K pathway mutations and with low inflammatory cytokine expression, P = 0.005)., Conclusions: Dacomitinib demonstrated clinical efficacy with manageable toxicity in platinum-failed R/M-SCCHN patients. Screening of PI3K pathway mutation and inflammatory cytokine expression may help identify which R/M-SCCHN patients are likely to gain benefit from dacomitinib., (©2014 American Association for Cancer Research.)
- Published
- 2015
- Full Text
- View/download PDF
48. Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.
- Author
-
Park JH, Kwon HJ, Park CS, and Hong S
- Abstract
This study reports a case of anaplastic transformation from a well-differentiated thyroid carcinoma in a young patient. The first recurrent tissue contained poorly differentiated foci that revealed lower thyroglobulin, thyroid transcription factor 1 (TTF-1), and galectin-3 expression than the well-differentiated area. However there was no increased p53 or Ki-67 expression in the poorly differentiated foci, nor in the well-differentiated area. The tissue subsequently relapsed and revealed only anaplastic features, complete loss of thyroglobulin, TTF-1, and galectin-3 expression and revealed an increase in p53 and Ki-67 expression. The BRAF V600E and BRAF V600V mutation were found in the initially diagnosed papillary thyroid carcinoma and the poorly differentiated foci of the recurring papillary thyroid carcinoma; however, only the BRAF V600V mutation was found in the anaplastic carcinoma. These results suggest that overexpression of p53 and Ki-67 contributed to the anaplastic transformation. We also found that the BRAF type changed during the tumor relapse.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.